A proof-of-concept study on the relationship between lifetime Estrogen exposure, menopausal transition, and neurodegeneration in women with multiple sclerosis
Open Access
- 4 March 2026
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 484, 125854
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Prediction of long-term outcome in Multiple Sclerosis: A systematic reviewMultiple Sclerosis and Related Disorders, 2025
- Treatment of Multiple Sclerosis: A ReviewThe American Journal of Medicine, 2020
- Clinical outcome measures in multiple sclerosis: A reviewAutoimmunity Reviews, 2020
- Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled TrialCNS Drugs, 2016
- Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis RelapsesJAMA Neurology, 2015
- Cumulative estrogen exposure and prospective memory in older womenBrain and Cognition, 2012
- Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injuryExperimental Neurology, 2011
- The multiple sclerosis functional composite: different practice effects in the three test componentsJournal of the Neurological Sciences, 2005
- Estrogen induces a potent suppression of experimental autoimmune encephalomyelities and collagen-induced arthritis in miceJournal of Neuroimmunology, 1994
- The Fatigue Severity ScaleArchives of Neurology, 1989